1. Home
  2. APLS vs UPST Comparison

APLS vs UPST Comparison

Compare APLS & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • UPST
  • Stock Information
  • Founded
  • APLS 2009
  • UPST 2012
  • Country
  • APLS United States
  • UPST United States
  • Employees
  • APLS N/A
  • UPST N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • UPST Finance: Consumer Services
  • Sector
  • APLS Health Care
  • UPST Finance
  • Exchange
  • APLS Nasdaq
  • UPST Nasdaq
  • Market Cap
  • APLS 4.4B
  • UPST 4.5B
  • IPO Year
  • APLS 2017
  • UPST 2020
  • Fundamental
  • Price
  • APLS $30.77
  • UPST $74.06
  • Analyst Decision
  • APLS Buy
  • UPST Hold
  • Analyst Count
  • APLS 19
  • UPST 11
  • Target Price
  • APLS $49.89
  • UPST $50.94
  • AVG Volume (30 Days)
  • APLS 4.2M
  • UPST 9.2M
  • Earning Date
  • APLS 11-05-2024
  • UPST 11-07-2024
  • Dividend Yield
  • APLS N/A
  • UPST N/A
  • EPS Growth
  • APLS N/A
  • UPST N/A
  • EPS
  • APLS N/A
  • UPST N/A
  • Revenue
  • APLS $715,216,000.00
  • UPST $604,944,000.00
  • Revenue This Year
  • APLS $95.59
  • UPST $4.81
  • Revenue Next Year
  • APLS $13.77
  • UPST $31.31
  • P/E Ratio
  • APLS N/A
  • UPST N/A
  • Revenue Growth
  • APLS 162.10
  • UPST 10.89
  • 52 Week Low
  • APLS $24.34
  • UPST $20.60
  • 52 Week High
  • APLS $73.80
  • UPST $86.07
  • Technical
  • Relative Strength Index (RSI)
  • APLS 59.23
  • UPST 68.56
  • Support Level
  • APLS $26.62
  • UPST $67.18
  • Resistance Level
  • APLS $30.80
  • UPST $75.19
  • Average True Range (ATR)
  • APLS 1.88
  • UPST 5.94
  • MACD
  • APLS 0.24
  • UPST 0.42
  • Stochastic Oscillator
  • APLS 96.69
  • UPST 68.43

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About UPST Upstart Holdings Inc. Common stock

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit and small dollar loans.

Share on Social Networks: